Stifel Financial Corp Fate Therapeutics Inc Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Stifel Financial Corp holds 41,487 shares of FATE stock, worth $147,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,487

Previous 43,790 5.26%

Holding current value

$147,278

Previous $321,000 57.63%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $7,507 - $16,305	-2,303 Reduced 5.26%	41,487 $136,000
Q1 2024 May 13, 2024	SELL	$3.54 - $8.35 $566 - $1,336	-160 Reduced 0.36%	43,790 $321,000
Q4 2023 Feb 12, 2024	SELL	$1.65 - $3.94 $33,295 - $79,505	-20,179 Reduced 31.47%	43,950 $164,000
Q3 2023 Nov 13, 2023	SELL	$2.02 - $5.04 $10,388 - $25,920	-5,143 Reduced 7.42%	64,129 $135,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $80,620 - $111,614	16,937 Added 32.36%	69,272 $329,000
Q1 2023 May 12, 2023	SELL	$4.24 - $11.12 $6,487 - $17,013	-1,530 Reduced 2.84%	52,335 $298,000
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $110,530 - $267,134	11,210 Added 26.28%	53,865 $543,000
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $80,393 - $137,785	-3,821 Reduced 8.22%	42,655 $956,000
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $24,963 - $59,515	1,404 Added 3.12%	46,476 $1.15 Million
Q1 2022 May 13, 2022	BUY	$29.67 - $60.28 $161,108 - $327,320	5,430 Added 13.7%	45,072 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $666,506 - $896,384	13,932 Added 54.19%	39,642 $2.32 Million
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $819,111 - $1.32 Million	13,820 Added 116.23%	25,710 $1.52 Million
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $214,796 - $295,508	3,194 Added 36.73%	11,890 $1.03 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $76,273 - $124,091	1,057 Added 13.84%	8,696 $717,000
Q4 2020 Feb 12, 2021	SELL	$38.09 - $100.95 $12,531 - $33,212	-329 Reduced 4.13%	7,639 $695,000
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $12,711 - $16,929	418 Added 5.54%	7,968 $318,000
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $152,585 - $265,986	7,550 New	7,550 $259,000

Others Institutions Holding FATE

# of Institutions

190

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $344M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Fate Therapeutics Inc Transaction History